0001125345-21-000038.txt : 20210309 0001125345-21-000038.hdr.sgml : 20210309 20210309195558 ACCESSION NUMBER: 0001125345-21-000038 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210308 FILED AS OF DATE: 20210309 DATE AS OF CHANGE: 20210309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peters Jeffrey Stuart CENTRAL INDEX KEY: 0001706903 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36112 FILM NUMBER: 21727738 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MACROGENICS INC CENTRAL INDEX KEY: 0001125345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: Rockville STATE: MD ZIP: 20850 BUSINESS PHONE: 301-251-5172 MAIL ADDRESS: STREET 1: 9704 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 wf-form4_161533774001831.xml FORM 4 X0306 4 2021-03-08 0 0001125345 MACROGENICS INC MGNX 0001706903 Peters Jeffrey Stuart 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 0 1 0 0 General Counsel Common Stock 2021-03-08 4 M 0 21749 11.50 A 21749 D Common Stock 2021-03-08 4 S 0 21749 26.50 D 0 D Employee stock option (right to buy) 11.5 2021-03-08 4 M 0 21749 0 D 2030-02-20 Common Stock 21749.0 65251 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2019. This transaction was executed in multiple trades at prices ranging from $26.50 to $26.63. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 12.5% of the options become exercisable 6 months after the date of grant and the remaining 87.5% shall vest in 14 substantially equal quarterly installments thereafter. /s/ Lynn Cilinski, Attorney-in-Fact 2021-03-09